Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors

Clinical Nuclear Medicine

Volumn 36, Issue 1, 2011, Pages 25-31

  Wong, Ka Kit ^a   Wynn, Elizabeth A ^a   Myles, Jamie ^a   Ackermann, Robert J ^a   Frey, Kirk A ^a   Avram, Anca M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

neuroendocrine tumor; somatostatin receptor scintigraphy; SPECT CT

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC TEST ACCURACY STUDY; DUAL TIME POINT; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROENDOCRINE TUMOR; PATHOLOGY; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINGLE TIME POINT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; SOMATOSTATIN; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 78651097800     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181feedc0     Document Type: Article

References (16)

1. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with-111In-DTPA-D-Phe1- and-123I-Tyr3-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
2. Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2006;36:228-247.
3. de Herder WW, Kwekkeboom DJ, Valkema R, et al. Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest. 2005;28(suppl): 132-146.
4. Ruf J, Steffen I, Mehl S, et al. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT. Nucl Med Commun. 2007;28:782-788.
5. Even-Sapir E, Keidar Z, Sachs J, et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med. 2001;42:998-1004.
6. Schillaci O, Danieli R, Manni C, et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun. 2004;25:705-710.
7. Roach PJ, Schembri GP, Ho Shon IA, et al. SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun. 2006;27:977-987.
8. Moreira AP, Duarte LH, Vieira F, et al. Value of SPET/CT image fusion in the assessment of neuroendocrine tumours with 111In-pentetreotide scintigraphy. Rev Esp Med Nucl. 2005;24:14-18.
9. Krausz Y, Keidar Z, Kogan I, et al. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol. 2003;59:565-573.
10. Perri M, Erba P, Volterrani D, et al. Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. Q J Nucl Med Mol Imaging. 2008;52:323-333.
11. Pfannenberg AC, Eschmann SM, Horger M, et al. Benefit of anatomicalfunctional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging. 2003;30:835-843.
12. Gabriel M, Hausler F, Bale R, et al. Image fusion analysis of (99m)Tc- HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours. Eur J Nucl Med Mol Imaging. 2005;32:1440-1451.
13. Amthauer H, Denecke T, Rohlfing T, et al. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur Radiol. 2005;15:1456-1462.
14. Hillel PG, van Beek EJ, Taylor C, et al. The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol. 2006;61:579-587.
15. Ingui CJ, Shah NP, Oates ME. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med. 2006;31:665-672.
16. Buck AK, Nekolla S, Ziegler S, et al. SPECT/CT. J Nucl Med. 2008;49: 1305-1319.